Director Ronald J. Pasek filed a Form 4 with the SEC on November 6, 2026, disclosing restricted stock unit transactions at Extreme Networks Inc. (NASDAQ:EXTR) dated November 4, 2026.
Michael J. Schlosser, EVP and Chief Clinical Officer of HCA Healthcare, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 1,200 shares of HCA Healthcare common stock on November 4, 2026.
Director Edward H. Kennedy filed a Form 4 with the SEC on November 6, 2026, reporting the vesting of 11,767 restricted stock units and the award of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.
Director Kathleen M. Holmgren filed a Form 4 with the SEC on November 6, 2026, disclosing the vesting of 11,767 restricted stock units and the grant of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.
Director Raj Khanna filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 11,767 shares of Extreme Networks common stock through the vesting of restricted stock units on November 4, 2026.
Chris J. Robertson, Controller at Agilysys, Inc., filed a statement of changes in beneficial ownership on November 6, 2026, disclosing the acquisition of 922 restricted stock units on November 4, 2026.
Director John C. Shoemaker filed a Form 4 with the SEC on November 6, 2026, reporting the vesting of 11,767 restricted stock units and the grant of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.
Director Charles Carinalli of Extreme Networks Inc filed a Form 4 on November 6, 2026, disclosing the vesting of 11,767 restricted stock units and the grant of 9,413 new restricted stock units on November 4, 2026.
Axalta Coating Systems Ltd. filed a Form 425 on November 6, 2026, disclosing that the European Commission granted conditional approval for the proposed all-stock merger of equals between Axalta and Akzo Nobel N.V., subject to a targeted divestiture remedy.
Douglas Krulik, CAO and Interim CFO of PetMed Express Inc., filed a Form 4 on November 6, 2026, reporting four share-surrender transactions between September 27, 2025, and October 30, 2026, related to the vesting of restricted stock units and restricted stock awards.